Fortitude Family Office’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-200
Closed -$5.98K 2113
2025
Q3
$5.98K Buy
200
+52
+35% +$1.74K ﹤0.01% 747
2025
Q2
$4.4K Buy
+148
New +$4.26K ﹤0.01% 833

Other funds holding SRDX

Fortitude Family Office's SRDX Position: Q4 2025 in Review

Fortitude Family Office sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 200 shares — an estimated $5.98K sold.

Fortitude Family Office first reported a position in SRDX in Q2 2025 and held it in 2 quarters. The position peaked at $5.98K in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Fortitude Family Office reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Fortitude Family Office sold 200 Surmodics shares in Q4 2025, an estimated $5.98K.
  • Fortitude Family Office first reported a position in Surmodics in Q2 2025 and held it in 2 quarters.
  • Fortitude Family Office's Surmodics position peaked at $5.98K in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.